Five China Stocks to Watch This Week 7 comments
-
Font Size:
-
Print
- TweetThis
1) Since Sinoenergy (SNEN.OB) announced its financial results on Monday, its shares have traded down on each of four consecutive sessions. The company has great fundamentals and is eminently positioned to take advantage of the spiking crude oil prices. But is its CNG filling station roll-out fast enough to meet investor expectations?
2) With little news, tourism and mass media concern China Yida Holding [IAVA.OB] was up more than 40% on Thursday, with the gain sustaining on Friday. Is there good news on the horizon?
3) China Water and Drinks (CWDK.OB) has been experiencing some very unusual share price movements lately on very low volume, going from $6 to top $15 and now back to $10.25, all in the space of ten days. What in the world is happening?
4) Profitable Guilin Paper [GUPR.OB] registered its 52-week low of $0.40 on 1/3, for no apparent reasons. If I thought this stock was buyable at around $1.00 (estimated FY2007 EPS $0.11), can one say "fire sale"?
5) On the other hand, in its quiet corner, Wuhan General Group (WUHN.OB) has been inching ever closer to its 52-week high, closing at $16 on Friday. Did you know the company is expecting record earnings this year by making environment-friendly power plant components?
My Position: Long IAVA.OB.
Related Articles
|






















This article has 7 comments:
Also, I want to buy the Chinese stocks (not ETFs). My broker says they don't trade in China. How can I trade directly in Chinese, Korean, India and HK markets (no ETFs)?
growthportfolio.ning.c...
scott
growthportfolio.ning.c...
scott
Additionally, there is one extremely undervalued China micro in LTUS.OB (Lotus Pharmaceuticals) that I believe is worth a closer look. This is a stock that has been oversold to the point where it now trades at a PE of 6 based on 2007 expected income of .18/share. The stock is thinly traded/unknown still, but that should change when their new IR firm is hired/announced.
LTUS has come off a triple bottom and was up 10% Thursday to $1.14/$1.20 on near-record volume and no news. Given the 100% income growth of LTUS yoy, their increasing margins, extensive drug pipeline, the hiring of a much needed IR firm which appears around the corner, and an extremely modest PE, LTUS.OB should be added to the list of "Ones to Watch".
Cheers,